BLUE - Bluebird bio Inc
4.97
0 0%
Share volume: 1,245,197
Last Updated: 05-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$4.97
0.00
0.00%
Summary score
24%
Profitability
0%
Dept financing
33%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.9%
Return on assets
-6.21%
Return on sales
-1010.45%
Return on invested capital
-21.32%
Total debt ratio
20.57%
Debt ratio change over timeo
0%
Current Ratio
11.57%
Quick Ratio
0%
Cash Position Ratio
4.67%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.36%
Return on assets
-5.77%
Return on sales
-1010.45%
Return on invested capital
-21%
Total debt ratio
20.67%
Debt ratio change over timeo
0%
Current Ratio
10.79%
Quick Ratio
0%
Cash Position Ratio
4.66%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-6.9%
Return on assets
-5.54%
Return on sales
-1010.45%
Return on invested capital
-13.82%
Total debt ratio
18.81%
Debt ratio change over time
0%
Current Ratio
9.88%
Quick Ratio
0%
Cash Position Ratio
3.1%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BLUE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -7.9% | 6.52% | 16.07% | 8% |
| Return on assets | -6.21% | 3.2% | 7.46% | 5.12% |
| Return on sales | -1010.45% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | -21.32% | 9.05% | 13.06% | 8.23% |
| Profitability | 0% | 57% | 100% | 63% |
| Total debt ratio | 20.57% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 33% | 23% | 25% | 18% |
| Current Ratio | 10.79% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 4.66% | 0.33% | 1.09% | 0.45% |
| Liquididy | 50% | 37% | 24% | 20% |
| Short-term ratios | BLUE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -7.36% | 6.57% | 13.54% | 7.21% |
| Return on assets | -5.77% | 3.23% | 6.63% | 5.05% |
| Return on sales | -1010.45% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | -21% | 9.41% | 12.01% | 7.62% |
| Profitability | 0% | 63% | 100% | 66% |
| Total debt ratio | 20.67% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 33% | 24% | 25% | 18% |
| Current Ratio | 10.79% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 4.66% | 0.33% | 1.09% | 0.45% |
| Liquididy | 50% | 39% | 27% | 18% |